Dynamics of Onchocerca volvulus Microfilarial Densities after Ivermectin Treatment in an Ivermectin-naïve and a Multiply Treated Population from Cameroon

PLoS Neglected Tropical Diseases

Volumn 7, Issue 2, 2013, Pages

  Pion, Sébastien D S ^a   Nana Djeunga, Hugues C ^b   Kamgno, Joseph ^b   Tendongfor, Nicholas ^c,d   Wanji, Samuel ^c   Njiokou, Flobert ^b   Prichard, Roger K ^e   Boussinesq, Michel ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c Research Foundation in Tropical Diseases and Environment   (Cameroon)

^d UNIVERSITY OF BUEA   (Cameroon)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; IVERMECTIN;

ADULT; ARTICLE; CAMEROON; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROFILARIA; ONCHOCERCIASIS; POPULATION DENSITY; POPULATION DYNAMICS; SKIN BIOPSY; TREATMENT RESPONSE;

EID: 84874786546     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002084     Document Type: Article

References (48)

1. Gustavsen K, Hopkins A, Sauerbrey M, (2011) Onchocerciasis in the Americas: from arrival to (near) elimination. Parasit Vectors 4: 205 doi:10.1186/1756-3305-4-205.
2. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, et al. (2009) Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3: e497 doi:10.1371/journal.pntd.0000497.t005.
3. Tekle A, Elhassan E, Isiyaku S, Amazigo UV, Bush S, et al. (2012) Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors 5: 28 doi:10.1186/1756-3305-5-28.
4. Basáñez M-G, Pion SD, Boakes E, Filipe JA, Churcher TS, et al. (2008) Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis 8: 310-322 doi:10.1016/S1473-3099(08)70099-9.
5. Ali MM, Mukhtar MM, Baraka OZ, Homeida MM, Kheir MM, et al. (2002) Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. Acta Trop 84: 49-53.
6. Schulz-Key H, (1990) Observations on the reproductive biology of Onchocerca volvulus. Acta Leiden 59: 27-44.
7. World Health Organization (2011) African Programme for Onchocerciasis Control: meeting of national task forces, September 2011. Wkly Epidemiol Rec 86: 541-549.
8. World Health Organization (2012) African Programme for Onchocerciasis Control (APOC), Achievements of community-directed treatment with ivermectin (CDTI). Available:http://www.who.int/apoc/cdti/achievements/en/index.html. Accessed 8 November 2012.
9. Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, et al. (2004) An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 231-249 doi:10.1179/000349804225003253.
10. Awadzi K, Attah S, Addy E, Opoku N, Quartey B, et al. (2004) Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 359-370 doi:10.1179/000349804225003442.
11. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK, (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369: 2021-2029.
12. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, et al. (2011) Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 5: e998 doi:10.1371/journal.pntd.0000998.t007.
13. Schulz-Key H, (1988) The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects. Trop Med Par 39 Suppl 4: 423-440.
14. Ardelli BF, Prichard RK, (2007) Reduced genetic variation of an Onchocerca volvulus ABC transporter gene following treatment with ivermectin. Trans R Soc Trop Med Hyg 101: 1223-1232 doi:10.1016/j.trstmh.2005.03.019.
15. Ardelli BF, Guerriero SB, Prichard RK, (2005) Genomic organization and effects of ivermectin selection on Onchocerca volvulus P-glycoprotein. Mol Biochem Parasitol 143: 58-66 doi:10.1016/j.molbiopara.2005.05.006.
16. Ardelli BF, Guerriero SB, Prichard RK, (2005) Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity. Parasitology 132: 375 doi:10.1017/S0031182005008991.
17. Ardelli BF, Guerriero SB, Prichard RK, (2006) Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus. Mol Biochem Parasitol 145: 94-100 doi:10.1016/j.molbiopara.2005.09.011.
18. Bourguinat C, Pion SD, Kamgno J, Gardon J, Duke BO, et al. (2007) Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl Trop Dis 1: e72 doi:10.1371/journal.pntd.0000072.
19. Bourguinat C, Ardelli BF, Pion SD, Kamgno J, Gardon J, et al. (2008) P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol Biochem Parasitol 158: 101-111 doi:10.1016/j.molbiopara.2007.11.017.
20. Eng JK, Prichard RK, (2005) A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol Biochem Parasitol 142: 193-202 doi:10.1016/j.molbiopara.2005.01.021.
21. Eng JK, Blackhall WJ, Osei-Atweneboana MY, Bourguinat C, Galazzo D, et al. (2006) Ivermectin selection on β-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol Biochem Parasitol 150: 229-235 doi:10.1016/j.molbiopara.2006.08.007.
22. Dicker AJ, Nisbet AJ, Skuce PJ, (2011) Gene expression changes in a P-glycoprotein (Tci-pgp-9) putatively associated with ivermectin resistance in Teladorsagia circumcincta. Int J Parasitol 41: 935-942 doi:10.1016/j.ijpara.2011.03.015.
23. Williamson SM, Storey B, Howell S, Harper KM, Kaplan RM, et al. (2011) Candidate anthelmintic resistance-associated gene expression and sequence polymorphisms in a triple-resistant field isolate of Haemonchus contortus. Mol Biochem Parasitol 180: 99-105 doi:10.1016/j.molbiopara.2011.09.003.
24. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue, et al, (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360: 203-210 doi:10.1016/S0140-6736(02)09456-4.
25. Moreau J, Prost A, Prod'hon J, (1978) Essai de normalisation de la méthodologie des enquêtes clinico-parasitologiques sur l'onchocercose en Afrique de l'ouest. Med Trop (Mars) 38: 43-51.
26. Awadzi K, Roulet H, Bell DR, (1980) The chemotherapy of onchocerciasis V. A standard method for the determination of microfilarial density in skin snips. Ann Trop Med Parasitol 74: 363-366.
27. Pion SD, Grout L, Kamgno J, Nana-Djeunga H, Boussinesq M, (2011) Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin. Acta Trop 120: S91-S99 doi:10.1016/j.actatropica.2010.05.004.
28. Churcher TS, Pion SD, Osei-Atweneboana MY, Prichard RK, Awadzi K, et al. (2009) Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci U S A 106: 16716-16721 doi:10.1073/pnas.0906176106.
29. Williams RL, (2000) A note on robust variance estimation for cluster-correlated data. Biometrics 56: 645-646.
30. StataCorp (2012) Stata: Release 12. Stata Press pp. 2324-2329.
31. StataCorp (2011) Stata Longitudinal-Data/Panel-Data Reference Manual Release 12. Stata Press pp. 19-22.
32. Albiez EJ, Büttner DW, Duke BO, (1988) Diagnosis and extirpation of nodules in human onchocerciasis. Trop Med Parasitol 39 Suppl 4: 331-346.
33. Boussinesq M, Gardon J, Kamgno J, Demanga-Ngangue, Pion SD, et al. (2001) Studies on the macrofilarial population of Onchocerca volvulus in hyper-endemic villages of the Central province of Cameroon. Ann Trop Med Parasitol 95: 379-388 doi:10.1080/00034980120064337.
34. Boussinesq M, Bourguinat C, Nana-Djeunga H, Pions SD, Kamgno J, et al. (2009) Ivermectin and Onchocerca volvulus: comparison of embryogrammes of adult worms collected from naive and multi-treated patients. Trop Med Int Health 14: 172.
35. Plaisier AP, Soumbey-Alley E, Boatin BA, Van Oortmarssen GJ, Remme H, et al. (1995) Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis 172: 204-210 doi:10.1093/infdis/172.1.204.
36. Bottomley C, Isham V, Collins RC, Basáñez M-G, (2008) Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology 135: 1571-1581 doi:10.1017/S0031182008000425.
37. Duerr HP, Dietz K, Büttner DW, Schulz-Key H, (2001) A stochastic model for the aggregation of Onchocerca volvulus in nodules. Parasitology 123: 193-201.
38. Burnham G, (2007) Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet 370: 1125 doi:10.1016/S0140-6736(07)61505-0.
39. Cupp E, Richards F, Lammie P, Eberhard M, (2007) Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet 370: 1123 doi:10.1016/S0140-6736(07)61501-3.
40. Hotez PJ, (2007) Control of onchocerciasis-the next generation. Lancet 369: 1979-1980 doi:10.1016/S0140-6736(07)60923-4.
41. Mackenzie CD, (2007) Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet 370: 1123-1124 doi:10.1016/S0140-6736(07)61503-7.
42. Remme JH, Amazigo U, Engels D, Barryson A, Yameogo L, (2007) Efficacy of ivermectin against Onchocerca volvulus in Ghana. The Lancet 370: 1123-1124 doi:10.1016/S0140-6736(07)61503-7.
43. Emukah EC, Osuoha E, Miri ES, Onyenama J, Amazigo U, et al. (2004) A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria. Am J Trop Med Hyg 70: 556-561.
44. Ozoh GA, Murdoch ME, Bissek A-C, Hagan M, Ogbuagu K, et al. (2011) The African Programme for Onchocerciasis Control: impact on onchocercal skin disease. Trop Med Int Health 16: 875-883 doi:10.1111/j.1365-3156.2011.02783.x.
45. Duerr HP, Raddatz G, Eichner M, (2008) Diagnostic value of nodule palpation in onchocerciasis. Trans R Soc Trop Med Hyg 102: 148-154.
46. Duerr HP, Raddatz G, Eichner M, (2011) Control of onchocerciasis in Africa: Threshold shifts, breakpoints and rules for elimination. Int J Parasitol 41: 581-589 doi:10.1016/j.ijpara.2010.12.009.
47. Meyer CG, Gallin M, Erttmann KD, Brattig NW, Schnittger L, et al. (2008) HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci U S A 91: 7515-7519.
48. Timmann C, Kamp EV, Kleensang A, König IR, Thye T, et al. (2008) Human genetic resistance to Onchocerca volvulus: evidence for linkage to chromosome 2p from an autosome-wide scan. J Infect Dis 198: 427-433 doi:10.1086/589720.